CYP2D6	drug_target	
CHRM4	drug_target	
CHRM3	drug_target	
RET	drug_target	
Infarction, Middle Cerebral Artery	phenotype	
CANX	drug_target	
Ziprasidone	drug	
DRD1	drug_target	
Ischaemic cerebral infarction	phenotype	
Alteplase	drug	
HTR3A	drug_target	
CHRM2	drug_target	
HTR1D	drug_target	
HTR2B	drug_target	
CYP3A5	drug_target	
CALR	drug_target	
PLAUR	drug_target	
HTR1B	drug_target	
HTR2A	drug_target	
CHRM1	drug_target	
HTR7	drug_target	
Cabozantinib	drug	
FGA	drug_target	
KDR	drug_target	
DRD4	drug_target	
DRD2	drug_target	
CYP1A2	drug_target	
KRT8	drug_target	
MET	drug_target	
ANXA2	drug_target	
HTR6	drug_target	
ADRA1A	drug_target	
CHRM5	drug_target	
SLC22A2	drug_target	
Tranexamic Acid	drug	
HRH1	drug_target	
PLG	drug_target	
HTR1E	drug_target	
Reteplase	drug	
HTR1A	drug_target	
Pramipexole	drug	
CYP3A4	drug_target	
ADRA1B	drug_target	
ADRA2A	drug_target	
CYP2C9	drug_target	
SLC22A1	drug_target	
SERPINE1	drug_target	
Tenecteplase	drug	
ADRA2C	drug_target	
ADRA2B	drug_target	
LRP1	drug_target	
SERPINB2	drug_target	
CLEC3B	drug_target	
HTR2C	drug_target	
DRD5	drug_target	
DRD3	drug_target	
SLC15A2	drug_target	
